TY  - JOUR
AU  - Noronha, Vanita
AU  - Patil, Vijay Maruti
AU  - Joshi, Amit
AU  - Prabhash, Kumar
PY  - 2018
TI  - Adding to the debate on once-a-week versus once-every-3-weeks cisplatin dosing in concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer
JF  - Therapeutic Radiology and Oncology; Vol 2 (December 2018): Therapeutic Radiology and Oncology
Y2  - 2018
KW  - 
N2  - One of the most popular debates in locally advanced head and neck squamous cell carcinoma (LAHNSCC) is the optimal dose and schedule of cisplatin when combined with radical radiotherapy in the curative setting, both postoperatively and as definitive chemoradiotherapy (CRT). Hoping to settle this debate once and for all, we conducted a phase III randomized clinical trial to answer this question (1).
UR  - https://tro.amegroups.org/article/view/4771